• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
GDG meetingDeclaration of Interests
First GDG meeting
(12th December 2007)
WT declared a personal pecuniary interest, private practice in urology. He did not declare a personal family interest. He declared a non-personal pecuniary interest, he is the principal local investigator in clinical trials with Allergan (not yet opened), Dianippo Sumuto, Yamanouchi (now Astellas), Schwarz Pharma. He is the principal local investigator in clinical trial with Novartis 2005-6. He declared a personal non-pecuniary interest, executive committee member section of female and reconstructive urology, British Association of Urological Surgeons. Author of papers, chapters and books on urology. Member of NICE Topic Selection Panel and Technology Appraisal Committee.
Second GDG Meeting
(13th December 2007)
No change
Third GDG Meeting
(17th March 2008)
No change
Fourth GDG Meeting
(30th April 2008)
No change
Fifth GDG Meeting
(6th June 2008)
No change
Sixth GDG Meeting
(14th July 2008)
No change
Seventh GDG Meeting
(8th September 2008)
No change
Eighth GDG Meeting
(15th October 2008)
No change
Ninth GDG Meeting
(27th November 2008)
No change
Tenth GDG Meeting
(16th January 2009)
No change
Eleventh GDG Meeting
(23rd February 2009)
No change
Twelfth GDG Meeting
(25th March 2009)
No change
Thirteenth GDG Meeting
(1st May 2009)
No change
Fourteenth GDG Meeting
(8th June 2009)
No change
Fifteenth GDG Meeting
(29th June 2009)
He declared a non-personal pecuniary interest; he stated that his participation in the clinical trial with Allergan never materialised. He declared that he knew of no personal pecuniary interest, personal family interest or personal non-pecuniary interest above those declared at the previous meeting.
ActionsNone required.

From: Appendix B, Declarations of interests

Cover of The Management of Lower Urinary Tract Symptoms in Men
The Management of Lower Urinary Tract Symptoms in Men [Internet].
NICE Clinical Guidelines, No. 97.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.